Comparison of lesion improvement in lupoid leishmaniasis patients with two treatment approaches: Trichloroacetic acid and intralesional meglumine antimoniate

Journal of Cutaneous Medicine and Surgery

Volumn 19, Issue 1, 2015, Pages 35-39

  Banihashemi, Mahnaz ^a   Yazdanpanah, Mohamad Javad ^a   Amirsolymani, Hossein ^a   Yousefzadeh, Hadis ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

MEGLUMINE ANTIMONATE; TRICHLOROACETIC ACID; ANTIPROTOZOAL AGENT; MEGLUMINE; MEGLUMINE ANTIMONIATE; ORGANOMETALLIC COMPOUND;

ADULT; ARM; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DYSPIGMENTATION; ERYTHEMA; FEMALE; HEAD; HUMAN; LEG; LEISHMANIASIS; LUPOID LEISHMANIASIS; MAJOR CLINICAL STUDY; MALE; NECK; PAIN; PARASITE CLEARANCE; PIGMENT DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCAR FORMATION; TREATMENT DURATION; TREATMENT OUTCOME; TRUNK; ADOLESCENT; CHILD; INTRALESIONAL DRUG ADMINISTRATION; LEISHMANIASIS, CUTANEOUS; PATHOLOGY; PRESCHOOL CHILD; SKIN; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIPROTOZOAL AGENTS; CHILD; CHILD, PRESCHOOL; HUMANS; INJECTIONS, INTRALESIONAL; LEISHMANIASIS, CUTANEOUS; MALE; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; SKIN; TREATMENT OUTCOME; TRICHLOROACETIC ACID; YOUNG ADULT;

EID: 84940984621     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.2310/7750.2014.13193     Document Type: Article

References (27)

1. Christopherson JB. Leishmaniasis of the skin resembling lupus vulgaris. Proc R Soc Med 1923;16(Dermatol Sect):48-50.
2. Bowling JC, Vega-Lopez F. Case 2. Lupoid leishmaniasis. Clin Exp Dermatol 2003;28:683-4, doi:10.1046/j.1365-2230.2003.01420.x.
3. Gurel MS, Ulukanligil M, Ozbilge H. Cutaneous leishmaniasis in Sanliurfa: epidemiologic and clinical features of the last four years (1997-2000). Int J Dermatol 2002;41:32-7, doi:10.1046/j.0011- 9059.2001.01396.x.
4. Valizadeh M, Dalimi Asl H, Fata A, et al. A study on Leishmania species causing cutaneous leishmaniasis in Mashhad using specific monoclonal antibodies. Modares J Med Sci 2005;7:107-13.
5. Gonzalez U, Pinart M, Reveiz L, et al. Interventions for Old World cutaneous leishmaniasis. Cochrane Database Syst Rev 2008;(4): CD005067.
6. Barrett MP, Croft SL. Management of trypanosomiasis and leishmaniasis. Br Med Bull 2012;104:175-96, doi:10.1093/bmb/ lds031.
7. Momeni AZ, Aminjavaheri M. Treatment of recurrent cutaneous leishmaniasis. Int J Dermatol 1995;34:129-33, doi:10.1111/j.1365- 4362.1995.tb03598.x.
8. Ganor S. The treatment of leishmaniasis recidivans with local injections of amphotericin B. Dermatol Int 1967;6:141-3, doi: 10.1111/j.1365-4362.1967.tb05251.x.
9. Babajev KB, Babajev OG, Korepanov VI. Treatment of cutaneous leishmaniasis using a carbon dioxide laser. Bull World Health Organ 1991;69:103-6.
10. Eissa MM, Soliman AS, Nassar SO. Ultrastructural and immunological features of experimental cutaneous leishmaniasis after treatment with intralesional hypertonic sodium chloride and CO2 laser rays. J Egypt Soc Parasitol 2003;33:329-52.
11. Mosleh IM, Geith E, Natsheh L, et al. Efficacy of a weekly cryotherapy regimen to treat Leishmania major cutaneous leishmaniasis. J Am Acad Dermatol 2008;58:617-24, doi:10.1016/ j.jaad.2007.12.032.
12. Reithinger R, Mohsen M, Wahid M, et al. Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial. Clin Infect Dis 2005;15:40:1148-55, doi:10.1086/428736.
13. Nilforoushzadeh MA, Sadeghian G, Jaffary F, et al. Successful treatment of lupoid cutaneous leishmaniasis with Glucantime and topical trichloroacetic acid (a case report). Korean J Parasitol 2008; 46:175-7, doi:10.3347/kjp.2008.46.3.175.
14. Nilforoushzadeh MA, Jaffary F, Reiszadeh MR. Comparative effect of topical trichloroacetic acid and intralesional meglumine antimoniate in the treatment of acute cutaneous leishmaniasis. Int J Pharmacol 2006;2:633-6, doi:10.3923/ijp.2006.633.636.
15. Lawrence N, Leonhardt JM. Trichloroacetic acid (TCA) peels. In: Rubin MG, Dover JS, Alam M, editors. Chemical peels. 9th ed. Philadelphia: Elsevier; 2006. p. 77-8.
16. Pezeshkpoor F, Banihashemi M, Yazdanpanah MJ, et al. Comparative study of topical 80% trichloroacetic acid with 35% trichloroacetic acid in the treatment of the common wart. J Drugs Dermatol 2012;11:e66-9.
17. Chun EY, Lee JB, Lee KH. Focal trichloracetic acid peel method for benign pigmented lesions in dark-skinned patients. Dermatol Surg 2004;30:512-6, doi:10.1111/j.1524-4725.2004.30166.x.
18. Sezer E, Erbil H, Kurumlu Z, et al. A comparative study of focal medium-depth chemical peel versus cryosurgery for the treatment of solar lentigo. Eur J Dermatol 2007;17:26-9.
19. Khunger N. Standard guidelines of care for chemical peels. Indian J Dermatol Venereol Leprol 2008;74 Suppl:S5-12.
20. Zanotti KM, Belinson J. Update on the diagnosis and treatment of human papillomavirus infection. Cleve Clin J Med 2002;69:948, 951-5, doi:10.3949/ccjm.69.12.948.
21. Najim RA, Sharquie KE, Al-Zubaidy SA. Possible mechanisms of action of the compounds injected intralesionally in the treatment of cutaneous leishmaniasis, in addition to their direct effects on the parasites. Ann Trop Med Parasitol 2006;100:33-8, doi:10.1179/ 136485906X78472.
22. Farah FS, Samra SA, Nuwayri-Salti N. The role of the macrophage in cutaneous leishmaniasis. Immunology 1975;29:755-64.
23. Murray HW, Berman JD, Davies CR, et al. Advances in leishmaniasis. Lancet 2005;366:1561-77, doi:10.1016/S0140-6736(05) 67629-5.
24. Dowlati Y. Cutaneous leishmaniasis: clinical aspect. Clin Dermatol 1996;14:425-31, doi:10.1016/0738-081X(96)00058-2.
25. Khatami A, Firooz A, Gorouhi F, et al. Treatment of acute Old World cutaneous leishmaniasis: a systematic review of the randomized controlled trials. J Am Acad Dermatol 2007;57:335, doi:10.1016/j.jaad.2007.01.016.
26. Murray HW, Berman JD, Davies CR, et al. Advances in leishmaniasis. Lancet 2005;366:1561-77, doi:10.1016/S0140-6736(05) 67629-5.
27. Croft SL, Seifert K, Yardley V. Current scenario of drug development for leishmaniasis. Indian J Med Res 2006;123: 399-410.